Biotech and Pharmaceuticals Medicine

  • Rep. Cummings: Don't believe Mylan's numbers this year

    Rep. Elijah Cummings (D-Maryland) reacts to the new report saying pre-tax profits on Mylan's EpiPen were 60 percent higher than CEO Heather Bresch told Congress last week. CNBC's Meg Tirrell reports.

  • Pro: Quite positive on Mylan's trajectory

    Discussing Mylan's EpiPen profit calculations and how to view the stock, with Ronny Gal, Sanford Bernstein Senior Analyst.

  • Mylan's drug pricing problem

    CNBC's Meg Tirrell reports the latest on Mylan's EpiPen profit numbers as told to Congress.

  • Betting on biotechs

    CNBC's Meg Tirrell reports the latest developments in Mylan's EpiPen pricing scandal. The "FMHR" traders and Jim Cramer weigh in.

  • Sept 26- Johnson& Johnson said on Monday that the U.S. Food and Drug Administration approved the company's blockbuster psoriasis drug, Stelara, for use in adults with Crohn's disease. The drug is approved in the United States to treat the skin condition scaly plaque psoriasis and a type of arthritis associated with psoriasis. These treatments include J&J's own...

  • Sept 26- Britain's GW Pharmaceuticals Plc said its experimental cannabis-derived drug for a rare form of childhood epilepsy succeeded in a third late-stage U.S. study. GW said it expects to submit a marketing application for the drug to the U.S. Food& Drug Administration in the first half of 2017. The company's shares rose as much as 10.2 percent to hit a record...

  • Amjevita is the fourth biosimilar to be approved by the FDA and is expected to be sold at a discount to the original drug. Unlike generics, which are interchangeable with their branded counterparts, biosimilars approved by the FDA to date are not considered interchangeable and therefore are not called generic. The FDA has determined, however, that there is no...

  • Amjevita is the fourth biosimilar to be approved by the FDA and is expected to be sold at a discount to the original drug. Unlike generics, which are interchangeable with their branded counterparts, biosimilars approved by the FDA to date are not considered interchangable and therefore are not called generic. The FDA has determined, however, that there is no...

  • The Copenhagen- based company said on Thursday both doses of the drug, idalopirdine, showed a "weak efficacy profile" and failed to reduce cognitive decline measured on a scale called ADAS-cog in the study named Starshine. Idalopirdine, which is being developed with Japan's Otsuka Pharmaceutical Co Ltd, is being tested in patients with mild to moderate...

  • The company was testing the drug in combination with donepezil, a compound that forms the core of Pfizer Inc's Alzheimer's treatment Aricept. The Copenhagen- based company said both doses of idalopirdine, which is being developed with Japan's Otsuka Pharmaceutical Co Ltd, also failed to meet the secondary goals of the study. Anders Gersel Pedersen, Chief...

  • SAN FRANCISCO, Sept 21- Facebook Chief Executive Mark Zuckerberg and his wife Priscilla Chan on Wednesday pledged more than $3 billion toward a plan to "cure, prevent or manage all disease within our children's lifetime." The event was attended by business and political luminaries including former Microsoft Corp Chairman Bill Gates, San Francisco Mayor Ed Lee...

  • SAN FRANCISCO, Sept 21- Facebook Chief Executive Mark Zuckerberg and his wife, Priscilla Chan, on Wednesday pledged more than $3 billion toward a plan to "cure, prevent or manage all disease within our children's lifetime." Investments will include a bioscience research center, called the Biohub, and plans for a chip to diagnose diseases, continuous bloodstream...

  • SAN FRANCISCO, Sept 21- Facebook Chief Executive Mark Zuckerberg and his wife Priscilla Chan on Wednesday pledged more than $3 billion toward a plan to "cure, prevent or manage all disease within our children's lifetime."

  • Mark Zuckerberg and his wife, Priscilla Chan.

    The Facebook co-founder and his wife believe we can prevent, diagnose and treat or cure all illnesses in their child's lifetime.

  • CHAN-ZUCKERBERG INITIATIVE PLEDGES TO INVEST MORE THAN $3 BILLION IN CURING AND MANAGING DISEASE- PRISCILLA CHAN.

  • SAN FRANCISCO— Facebook CEO Mark Zuckerberg has a goal that's even more ambitious than connecting the entire world to the internet: He and his wife want to help eradicate all disease by the end of this century. Zuckerberg and Priscilla Chan are committing $3 billion over the next 10 years to accelerate basic scientific research, including the creation of...

  • Sept 21- The United States could save at least $15.5 billion in annual healthcare spending if malnutrition caused by chronic diseases is better addressed, according to a study. The study, conducted by Abbott Laboratories' nutrition division and the University of Illinois, noted one in three patients who arrive at a U.S.-hospital suffer from malnutrition.

  • Bill George on Mylan CEO: Showed very little empathy for consumer

    Bill George, Harvard Business School Senior Fellow and Former Medtronic Chairman, weighs in on Mylan CEO Heather Bresch's upcoming testimony on Capitol Hill over the EpiPen pricing debate.

  • Stocks to Watch: September 21, 2016

    General Mills, Quest Diagnostics and Boston Beer are making waves on Wall Street this Wednesday morning.

  • Quest Diagnostics launches Zika antibody test service

    CNBC's Meg Tirrell reports there is a new Zika test licensed by the Centers for Disease Control.